Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 33 X posts from 24 X users, with an upper bound of 357,367 followers.

check out @vkprasadlab works on this topic ➡️https://t.co/Z99Bl49Wm1 our CM816 analysis ➡️https://t.co/4A809yWS7N CPI trials in neo/adj setting @anushka_walia4 and @VPrasadMDMPH

RT @VPrasadMDMPH: This thread can't do the paper justice. It's really a tour de force by @anushka_walia4 Who has also written on VTE http…

RT @VPrasadMDMPH: This thread can't do the paper justice. It's really a tour de force by @anushka_walia4 Who has also written on VTE http…

RT @VPrasadMDMPH: This thread can't do the paper justice. It's really a tour de force by @anushka_walia4 Who has also written on VTE http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 29 additional X posts.